There’s a lot to be optimistic about in the Services sector as 2 analysts just weighed in on Charter Communications (CHTR) and ALX Oncology Holdings (ALXO) with bullish sentiments.
Charter Communications (CHTR)
In a report issued on January 26, Bernie McTernan from Rosenblatt Securities maintained a Buy rating on Charter Communications, with a price target of $765.00. The company’s shares closed last Thursday at $624.23.
According to TipRanks.com, McTernan is a 5-star analyst with an average return of 31.9% and a 78.5% success rate. McTernan covers the Services sector, focusing on stocks such as Penn National Gaming, Peloton Interactive, and World Wrestling.
Currently, the analyst consensus on Charter Communications is a Strong Buy with an average price target of $742.29, a 18.5% upside from current levels. In a report issued on January 15, KeyBanc also maintained a Buy rating on the stock with a $771.00 price target.
See today’s analyst top recommended stocks >>
ALX Oncology Holdings (ALXO)
LifeSci Capital analyst Adam Evertts PhD assigned a Buy rating to ALX Oncology Holdings on March 5 and set a price target of $100.00. The company’s shares closed last Thursday at $76.33.
PhD has an average return of 53.6% when recommending ALX Oncology Holdings.
According to TipRanks.com, PhD is ranked #1487 out of 7372 analysts.
ALX Oncology Holdings has an analyst consensus of Strong Buy, with a price target consensus of $98.83, representing a 30.9% upside. In a report issued on March 5, Piper Sandler also maintained a Buy rating on the stock with a $97.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.